Good news on World Malaria Day: A new ELISA test is available which can reliably and quickly detect an infection with the dangerous tropical disease. Moreover, a new „travel kit“ will enable travelers to test themselves.
Even though the number of new diseases and deaths has decreased in recent years, malaria is still one of the most common infectious diseases worldwide and one of the largest health problems, especially in Africa. As reported by the Robert Koch Institute, 40 % of the world’s population live in endemic areas. According to the WHO World Malaria Report, there were more than 200 million cases of malaria in 2016 and 445.000 deaths. In Germany, more than 500 cases are recorded each year. The disease is caused by infection with the Plasmodium parasite, transmitted by the bite of the female Anopheles mosquito. There are several types of malaria that can be caused by different Plasmodium species. The most dangerous is falciparum malaria caused by the Plasmodium falciparum parasite. This type of malaria can be fatal if it is not treated soon enough. An early diagnosis is therefore crucial.
The standard method for diagnosing malaria is the detection of Plasmodium in the peripheral blood using a Giemsa-stained “thick drop”. This analysis is sensitive and relatively inexpensive, but also very time-consuming and requires experienced laboratory personnel. Faster and easier alternatives include enzyme immunoassays (ELISA) and immunochromatographic rapid tests. R-Biopharm uses these two technologies in its new extended portfolio for malaria diagnostics, providing reliable solutions for traditional laboratory diagnostics. The new ELISA test is now available and can be used for confirmatory diagnostics or differential diagnosis. Moreover, there will soon be an extended application for the already available rapid test in the form of a “travel kit” suitable even for laymen. This was successfully confirmed in a study by the BCRT in Berlin involving almost 100 test persons; a study report is available and the approval has been applied for.
NEW: The RIDASCREEN® Malaria Ab-Screening (Art. No. K8341) is an enzyme immunoassay to qualitatively detect specific IgG and IgM antibodies against the malaria virus in human serum or plasma.
- High sensitivity
- High specificity
- High sample throughput and automation possible
The RIDA®QUICK Malaria (Art. No. N7006/N7007) is an immunochromatographic rapid test to qualitatively detect Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale and Plasmodium malariae antigens in whole blood.
- High specificity and sensitivity
- Fast results in 30 minutes
- Easy to use